Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates

被引：21

作者：

Canton, Rafael ^{[1
,2
,3
]}

Morrissey, Ian ^{[4
]}

Vila, Jordi ^{[3
,5
,6
]}

Tato, Marta ^{[1
,2
,3
]}

Garcia-Castillo, Maria ^{[1
,2
,3
]}

Lopez, Yuly ^{[6
]}

Gargallo-Viola, Domingo ^{[7
]}

Zsolt, Ilonka ^{[7
]}

机构：

[1] Hosp Univ Ramon & Cajal, Serv Microbiol, Madrid, Spain

[2] IRYCIS, Madrid, Spain

[3] REIPI, Madrid, Spain

[4] IHMA Europe Sarl, Monthey, Switzerland

[5] Hosp Clin Barcelona, Ctr Diagnst Biomed, Microbiol Serv, Barcelona, Spain

[6] Inst Global Hlth Barcelona, Barcelona, Spain

[7] Ferrer Int, Dept Med, Barcelona, Spain

来源：

FUTURE MICROBIOLOGY | 2018年 / 13卷 / 06期

关键词：

antibacterial activity; clinical isolates; Gram-positive; MRSA; ozenoxacin; IMPETIGO;

D O I：

10.2217/fmb-2017-0289

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Aim: To compare the in vitro activity of the anti-impetigo agent, ozenoxacin, and other antimicrobial agents against Gram-positive clinical isolates from skin and soft tissue infections. Materials & methods: Isolates were collected in two studies: 1097 isolates from 49 centers during 2009-2010 and 1031 isolates from ten centers during 2014. Minimum inhibitory concentrations were determined for 18 and 11 antimicrobials in these studies, respectively, using standard broth microdilution methods. Isolates were stratified by species and methicillin susceptibility/resistance and/or levofloxacin susceptibility/nonsusceptibility status. Results: Ozenoxacin exhibited high in vitro activity against Staphylococcus aureus and coagulase-negative staphylococci isolates in both studies. Ozenoxacin was also highly active against Streptococcus pyogenes and Streptococcus agalactiae isolates. Conclusion: Ozenoxacin is a potent antimicrobial agent against staphylococci and streptococci.

引用

页码：3 / 19

页数：18

共 17 条

[11] In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan [J].

Kanayama, Shoji ;

Ikeda, Fumiaki ;

Okamoto, Kazuaki ;

Nakajima, Akiko ;

Matsumoto, Tatsumi ;

Ishii, Ritsuko ;

Amano, Ayako ;

Matsuzaki, Kaoru ;

Matsumoto, Satoru .

JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (9-10) :720-723

[12] Interventions for impetigo [J].

Koning, Sander ;

van der Sande, Renske ;

Verhagen, Arianne P. ;

van Suijlekom-Smit, Lisette W. A. ;

Morris, Andrew D. ;

Butler, Christopher C. ;

Berger, Marjolein ;

van der Wouden, Johannes C. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01)

[13] In Vitro Activity of Ozenoxacin against Quinolone-Susceptible and Quinolone-Resistant Gram-Positive Bacteria [J].

Lopez, Y. ;

Tato, M. ;

Espinal, P. ;

Garcia-Alonso, F. ;

Gargallo-Viola, D. ;

Canton, R. ;

Vila, J. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) :6389-6392

[14] Antimicrobial activities of ozenoxacin against isolates of propionibacteria and staphylococci from Japanese patients with acne vulgaris [J].

Nakajima, Akiko ;

Ikeda, Fumiaki ;

Kanayama, Shoji ;

Okamoto, Kazuaki ;

Matsumoto, Tatsumi ;

Ishii, Ritsuko ;

Fujikawa, Akira ;

Takei, Katsuaki ;

Kawashima, Makoto .

JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 65 :745-750

[15]

Pereira LB, 2014, AN BRAS DERMATOL, V89, P293

[16] Common skin infections in children [J].

Sladden, MJ ;

Johnson, G .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7457) :95-99

[17] In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone [J].

Yamakawa, T ;

Mitsuyama, J ;

Hayashi, K .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :455-465

← 1 2 →